Page last updated: 2024-09-05

tesaglitazar and thiophenes

tesaglitazar has been researched along with thiophenes in 4 studies

Compound Research Comparison

Studies
(tesaglitazar)
Trials
(tesaglitazar)
Recent Studies (post-2010)
(tesaglitazar)
Studies
(thiophenes)
Trials
(thiophenes)
Recent Studies (post-2010) (thiophenes)
74132517,0121,9618,038

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Charbonnel, B1
Blander, G; Bobadilla, M; Catlett, NL; Deehan, R; Edgar, A; Elliston, KO; Haefliger, C; Ladd, W; Maerz-Weiss, P; Mizrahi, J; Steiner, G; Wong, B; Wright, MB1
Farkouh, M; Plutzky, J; Rosenson, RS; Wright, RS1
Drosatos, K; Kalliora, C1

Reviews

2 review(s) available for tesaglitazar and thiophenes

ArticleYear
Modulating peroxisome proliferator-activated receptors for therapeutic benefit? Biology, clinical experience, and future prospects.
    American heart journal, 2012, Volume: 164, Issue:5

    Topics: Alkanesulfonates; Diabetic Angiopathies; Glycine; Humans; Hypoglycemic Agents; Insulin Resistance; Ligands; Oxazines; Oxazoles; Phenylpropionates; Phosphorylation; PPAR alpha; PPAR delta; PPAR gamma; Thiazolidinediones; Thiophenes; United States; United States Food and Drug Administration

2012
The Glitazars Paradox: Cardiotoxicity of the Metabolically Beneficial Dual PPARα and PPARγ Activation.
    Journal of cardiovascular pharmacology, 2020, Volume: 76, Issue:5

    Topics: Alkanesulfonates; Animals; Cardiotoxicity; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Energy Metabolism; Glycine; Humans; Hypoglycemic Agents; Oxazoles; Phenylpropionates; PPAR alpha; PPAR gamma; Risk Assessment; Risk Factors; Signal Transduction; Thiophenes

2020

Other Studies

2 other study(ies) available for tesaglitazar and thiophenes

ArticleYear
PPAR-alpha and PPAR-gamma agonists for type 2 diabetes.
    Lancet (London, England), 2009, Jul-11, Volume: 374, Issue:9684

    Topics: Alkanesulfonates; Clinical Trials, Phase II as Topic; Diabetes Mellitus, Type 2; Glycine; Humans; Hypoglycemic Agents; Oxazoles; Phenylpropionates; PPAR alpha; PPAR gamma; Thiophenes

2009
Comparative transcriptional network modeling of three PPAR-α/γ co-agonists reveals distinct metabolic gene signatures in primary human hepatocytes.
    PloS one, 2012, Volume: 7, Issue:4

    Topics: Alkanesulfonates; Cells, Cultured; Fenofibrate; Hepatocytes; Humans; Oxazoles; Phenylpropionates; Pioglitazone; PPAR alpha; PPAR gamma; Thiazolidinediones; Thiophenes

2012
chemdatabank.com